MOLECULAR GENETIC MARKERS FOR DIAGNOSING METACHRONOUS ONCOGYNECOLOGICAL TUMORS IN BREAST CANCER PATIENTS

dc.contributor.authorIzrailbekova K.Sh
dc.contributor.authorKamishov S.V
dc.contributor.authorQobilov O.R
dc.contributor.authorNiyozova Sh.Kh
dc.contributor.authorUbaydullaeva M.J
dc.date.accessioned2026-01-09T20:33:06Z
dc.date.issued2026-01-06
dc.description.abstractBreast cancer (BC) patients face an increased risk of developing multiple primary malignant tumors, particularly metachronous oncogynecological neoplasms. Early detection and risk stratification of these secondary malignancies are critical for improving patient outcomes.
dc.formatapplication/pdf
dc.identifier.urihttps://westerneuropeanstudies.com/index.php/3/article/view/3206
dc.identifier.urihttps://asianeducationindex.com/handle/123456789/110186
dc.language.isoeng
dc.publisherWestern European Studies
dc.relationhttps://westerneuropeanstudies.com/index.php/3/article/view/3206/2243
dc.rightshttps://creativecommons.org/licenses/by-nc/4.0
dc.sourceWestern European Journal of Medicine and Medical Science; Vol. 4 No. 01 (2026): WEJMMS; 10-18
dc.source2942-1918
dc.subjectbreast cancer
dc.subjectmetachronous tumors
dc.subjectmolecular genetic markers
dc.titleMOLECULAR GENETIC MARKERS FOR DIAGNOSING METACHRONOUS ONCOGYNECOLOGICAL TUMORS IN BREAST CANCER PATIENTS
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion
dc.typePeer-reviewed Article

item.page.files

item.page.filesection.original.bundle

pagination.showing.labelpagination.showing.detail
loading.default
thumbnail.default.alt
item.page.filesection.name
ksh_2026_molecular_genetic_markers_for_diagnosing.pdf
item.page.filesection.size
272.54 KB
item.page.filesection.format
Adobe Portable Document Format

item.page.collections